2,2,5,7,8-pentamethyl-1-hydroxychroman and thromboxane b2

2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with thromboxane b2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hung, WC; Kan, YC; Lee, CR; Lee, YM; Lin, CC; Lin, CH; Sheu, JR; Yen, MH	1

Other Studies

1 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and thromboxane b2

Article	Year
The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. British journal of pharmacology, 1999, Volume: 127, Issue:5 Topics: Antioxidants; Calcium; Chromans; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Humans; Phosphatidylinositols; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboxane B2; Thromboxane-A Synthase	1999

Article

Year

The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.

British journal of pharmacology, 1999, Volume: 127, Issue:5

Topics: Antioxidants; Calcium; Chromans; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Humans; Phosphatidylinositols; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboxane B2; Thromboxane-A Synthase

1999